The Rapid Economy

SEBI has announced a  special six-month window  from  July 7, 2025, to January 6, 2026 , giving investors a final opportunity to  resubmit old physical share transfer requests  that were previously rejected or returned due to documentation issues. This initiative specifically covers  transfer deeds lodged before April 1, 2019 , which could not be processed earlier because of incomplete or incorrect paperwork. All shares re-lodged during this window will be transferred only in dematerialised (demat) form , in line with SEBI’s push for a fully digital securities market. The move comes after SEBI received numerous appeals from investors, listed companies, and Registrar & Transfer Agents (RTAs), who highlighted that many shareholders missed the earlier cut-off date of March 31, 2021, due to various difficulties. A panel of legal experts, RTAs, and company representatives reviewed the situation and recommended this one-time relief to protect investor rights ...

The government has announced that  state-run oil marketing companies (OMCs) — BPCL, HPCL, and IOCL — will receive full compensation for losses exceeding Rs 40,000 crore incurred in FY24  due to subsidized LPG sales. Petroleum and Natural Gas Minister Hardeep Singh Puri assured there is "100% certainty" that the finance ministry will release the compensation in full , ending months of uncertainty for these companies. The losses stemmed from  keeping LPG cylinder prices artificially low for consumers, especially beneficiaries of the PM Ujjwala Yojana , despite international LPG prices surging by over 60% in 2023–24. While the effective price for PMUY consumers in Delhi was maintained at Rs 503 per cylinder, the actual market-linked price soared above Rs 1,050, forcing OMCs to absorb the difference. This move is expected to significantly improve the financial health and balance sheets of BPCL, HPCL, and IOCL , which have faced volatile profits due to price freezes and rising...

Credila Financial Services, a leading education loan provider, has filed its updated draft red herring prospectus (DRHP) with SEBI for a blockbuster ₹5,000 crore initial public offering (IPO). The IPO will consist of a fresh issue of shares worth ₹3,000 crore and an offer for sale (OFS) of ₹2,000 crore by existing shareholders. In the OFS, promoter entity Kopvoorn BV (an affiliate of EQT Private Capital Asia) will offload shares worth ₹950 crore, while HDFC Bank will sell shares valued at ₹1,050 crore. The company is also eyeing a pre-IPO placement of up to ₹600 crore; if successful, this will reduce the fresh issue component accordingly. Founded in 2006, Credila has emerged as India’s largest education-focused NBFC, with a loan book of ₹41,469 crore and a net profit of ₹990 crore for FY25. The IPO aims to strengthen Credila’s capital base and fuel its ambitious expansion plans in the booming education finance sector. This high-profile public issue comes after regulatory changes and a ...

Pine Labs, the Noida-based fintech powerhouse, has officially filed its Draft Red Herring Prospectus (DRHP) with SEBI, setting the stage for a blockbuster Rs 2,600 crore initial public offering (IPO). The IPO will feature a fresh issue of shares worth Rs 2,600 crore, alongside an offer for sale (OFS) of up to 147.8 million shares by early backers and key investors. Heavyweight investors including Peak XV Partners (formerly Sequoia India), Temasek, PayPal, Mastercard, Invesco, Actis, Madison India, and co-founder Lokvir Kapoor are all set to partially cash out in this highly anticipated market debut. Peak XV emerges as the lead seller, offloading nearly 39 million shares, while PayPal, Mastercard, and Temasek are also trimming their stakes. Co-founder Lokvir Kapoor will be reducing his holding as well. The IPO will be managed by a star-studded lineup of bankers: Axis Capital, Morgan Stanley, Citi, JP Morgan, and Jefferies. Pine Labs plans to list its shares on both the National Stock Ex...

Lupin Limited, a leading Mumbai-based pharma giant, has secured final approval from the US Food and Drug Administration (USFDA) for its Prucalopride Tablets, 1 mg and 2 mg, designed to treat chronic idiopathic constipation (CIC) in adults. These tablets are bioequivalent to Motegrity® by Takeda Pharmaceuticals, targeting a US market with estimated annual sales of $184 million. The approved Prucalopride Tablets will be manufactured at Lupin’s world-class facility in Goa, India, further cementing the company’s manufacturing prowess. This milestone is set to boost Lupin’s already robust US product portfolio, strengthening its position in the fiercely competitive American pharmaceutical market. The approval comes on the heels of Lupin’s strong Q4 performance, with revenue rising 12.2% year-on-year to ₹5,567.1 crore and EBITDA climbing 22.5% to ₹996.85 crore. Lupin’s US business continues to be a key growth driver, and the latest FDA green light is expected to provide a significant revenue ...

DLF’s latest luxury residential project,  Privana North  in Gurugram, has achieved a record-breaking feat by selling units worth a staggering Rs 11,000 crore within just one week of launch. The project is part of the expansive 116-acre DLF Privana township, strategically located in Sectors 76 and 77, offering seamless connectivity to major expressways and the airport. Privana North stands out with six iconic towers, each soaring to 50 storeys, making them the tallest residential structures ever developed by DLF. The development features 1,152 spacious 4 BHK residences and 12 ultra-premium penthouses, all designed with expansive living spaces, panoramic views, and unmatched privacy in the sky. Buyers from across India and the globe rushed to book homes, reflecting a surging demand for luxury living and DLF’s trusted brand legacy. Residents will enjoy exclusive amenities, a low-density environment, lush green landscapes, and proximity to over 1,000 acres of reserved forest and t...

Reliance Aerostructure, a subsidiary of Reliance Infrastructure, has joined hands with French aerospace giant Dassault Aviation to manufacture Falcon 2000 business jets in India—a first outside France. The landmark agreement was unveiled at the Paris Air Show, signaling a major leap for India’s aerospace ambitions and the government’s ‘Make in India’ initiative. The state-of-the-art final assembly line will be set up in Nagpur, Maharashtra, at the Dassault Reliance Aerospace Ltd (DRAL) facility. DRAL will become the first Centre of Excellence for the Falcon series outside France, handling not just the Falcon 2000 but also the assembly of Falcon 6X and 8X jets. India now joins an elite club of nations—alongside the US, France, Canada, and Brazil—that manufacture next-generation business jets. The first ‘Made-in-India’ Falcon 2000 is expected to take flight by 2028, marking a new era for Indian aviation and global exports. The partnership includes the transfer of advanced assembly operat...